Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2003
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104625 Novel oncolytic adenoviral vectors
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
06/05/2003US20030104578 Secreted in yeast; storage stability; microbiocides
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104568 Monitoring electrical transfer between transgenic cell and heart muscle tissue; electroconductivity analysis; tissue engineering
06/05/2003US20030104532 Neuroprotectants; angoigenesis inhibitors; transcription factors
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104482 Death associated kinase containing ankyrin repeats (DAKAR)
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104077 Relieving symptoms of erectile dysfunction with proanthocyanidins
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104016 Reducing inflammation by topically applying totarol or an ester of totarol
06/05/2003US20030104006 Hyaluronidase activity and allergenic cell activity inhibitor
06/05/2003US20030104005 Physiologically active compositions based upon active ingredients of basidiomycotina and araliaceae
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103963 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/05/2003US20030103957 Comprises adenosine-diphosphate transferase activity; drug delivery; for suppressing inhibition of neuronal axon growth
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003US20030103936 Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides
06/05/2003US20030103912 Breaking, disrupting film in aqueous solution; preventioncoagulation
06/05/2003US20030101995 Dry powder inhalation system for transpulmonary administration
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2837936A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2477585A1 Amino acid derivatives useful for the treatment of alzheimer's disease
06/05/2003CA2471833A1 Methods of compositions for normalizing lipid levels in mammalian tissues
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468575A1 Oral immunostimulation of mammals, birds, fish and reptiles from (1-4) linked .beta.-d-mannuronic acid
06/05/2003CA2468548A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468501A1 T-cell epitodes in carboxypeptidase g2
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468402A1 Ccr-3 receptor antagonists vii
06/05/2003CA2468292A1 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003CA2468246A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003CA2468192A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468154A1 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
06/05/2003CA2468131A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2468010A1 Benzazepine derivatives and their use as 5-ht ligands
06/05/2003CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467874A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003CA2467677A1 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466677A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
06/05/2003CA2466478A1 Gene therapy agents for neurodegenerative diseases
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2465846A1 Targeted therapeutics and uses thereof
06/05/2003CA2413315A1 Antithrombin for the prevention and therapy of vasculoproliferative disorders
06/04/2003EP1316561A1 Fusion protein having enhanced in vivo erythropoietin activity
06/04/2003EP1316558A1 Tetraphenylbacteriochlorin derivatives and compositions containing the same
06/04/2003EP1316552A1 Processing method of lactonization in the preparation of statins
06/04/2003EP1316549A1 1-benzyl-4- (5,6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1316316A1 Preparations for oral administration
06/04/2003EP1316315A1 Medicinal compositions
06/04/2003EP1316313A2 Composition for the treatment of ischemic stroke containing zonampanel and a tissue plasminogen activator
06/04/2003EP1316306A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316305A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316304A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316303A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316302A1 Cosmetic and/or dermatological composition containing at least one oxidation sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1315970A1 Nucleic acid sequences and proteins involved in cellular senescence
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315837A2 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
06/04/2003EP1315831A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315813A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315809A2 Control of crop pests and animal parasites through direct neuronal uptake
06/04/2003EP1315807A2 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315793A1 Methods for culturing human lung mast cells and uses thereof
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315754A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315752A1 Modified proteins, isolated novel peptides, and uses thereof
06/04/2003EP1315751A2 Two receptors of meiosis activating sterols designated sam1a and sam1b
06/04/2003EP1315750A2 Cyclic peptides having melanocortin-4 receptor agonist activity
06/04/2003EP1315743A2 Mammalian genes; related reagents and methods
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315741A2 A method for treating allergies
06/04/2003EP1315736A2 Nucleoside derivatives for the treatment of hepatitis c
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315732A2 Radicicol and monocillin and their analogues and uses thereof
06/04/2003EP1315730A1 1-(alkyl), 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo(1,2-a)pyrimidin-5(1h)-one derivatives
1 ... 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 ... 1564